This inventor holds 75 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Hepatitis Antiviral Agents (CPC class A61K). Top assignees: Enanta Pharmaceuticals, Inc., Novartis Ag. Active years: 2003-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Somerville, MA (US) (2003 - 2004)
- Andover, MA (US) (2004 - 2024)
Company Filing History:
75 out of 299 
1 out of 3,978 
Years Active: 2003-2025
Areas of Expertise:
Title: Yao-Ling Qiu: Innovator in Antiviral Agents
Introduction
Yao-Ling Qiu, an accomplished inventor based in Andover, MA, has made significant contributions to the field of antiviral agents, particularly in the treatment of Hepatitis B virus (HBV). With a remarkable portfolio of 74 patents, Qiu stands out as a leading figure in pharmaceutical innovation.
Latest Patents
Among his latest inventions, Qiu has developed novel Hepatitis B antiviral agents. These compounds, represented by Formula (I), are designed to inhibit the proteins encoded by the hepatitis B virus, thereby interfering with the viral life cycle. These compounds not only function as antiviral agents but also form the basis for pharmaceutical compositions aimed at treating subjects suffering from HBV infection. The inventive methodologies proposed include administering these compositions to effectively combat the HBV infection.
Career Highlights
Qiu has an extensive career in the pharmaceutical industry, having worked with notable companies, including Enanta Pharmaceuticals, Inc. and Novartis AG. His innovative spirit and dedication to research are evident in his extensive patent portfolio, which reflects his commitment to advancing antiviral therapies.
Collaborations
Throughout his career, Qiu has collaborated with other esteemed professionals. Among his notable coworkers are Yat Sun Or and Xiaowen Peng, both of whom contribute their expertise to the field and complement Qiu's research efforts.
Conclusion
Yao-Ling Qiu's work in developing antiviral agents for Hepatitis B showcases his dedication to medical innovation. With numerous patents to his name and impactful collaborations, Qiu continues to push the boundaries of pharmaceutical research and development. His contributions are helping to pave the way for new treatments that could significantly improve the lives of those affected by HBV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile